FB Financial (US:FBK) Benzinga·2025-07-15 12:40Group 1 - U.S. stock futures are higher, with Nasdaq futures gaining approximately 100 points [1] - Simulations Plus, Inc. reported quarterly earnings of 45 cents per share, exceeding the analyst consensus estimate of 7 cents per share [2] - Simulations Plus reported quarterly sales of $20.363 million, which fell short of the analyst consensus estimate of $20.878 million [2] - Keybanc analyst downgraded Simulations Plus from Overweight to Sector Weight, leading to a 6.3% dip in shares to $16.37 in pre-market trading [2] Group 2 - Presidio Property Trust, Inc. shares fell 29.9% to $9.55 after a significant 166% increase on Monday, following a $2.05 million registered direct offering [4] - MiNK Therapeutics, Inc. shares declined 27.5% to $29.45 after a 37% drop on Monday, with an analyst downgrade from Outperform to Market Perform [4] - Organogenesis Holdings Inc. shares dropped 26.7% to $3.29 after gaining over 4% on Monday [4] - MiMedx Group, Inc. shares fell 20.7% to $5.38 in pre-market trading [4] - Sequans Communications S.A. shares declined 10.8% to $5.01 after a 20% increase on Monday due to Bitcoin acquisition news [4] - Iovance Biotherapeutics, Inc. shares decreased 5.5% to $1.8990 in pre-market trading [4] - FB Financial Corporation shares fell 5.4% to $46.50 following disappointing quarterly sales [4] - ProKidney Corp. shares dropped 4.6% to $3.52 after filing for a common stock offering of up to $200 million [4] - Blue Gold Limited shares declined 4.5% to $26.60 after a 30% surge on Monday [4]